BioIndustry Association

Activities: Media Training & Education

Trending Articles

  1. Actylis expands into VMS & Pharma with the acquisition of Pharm-Rx The acquisition strengthens Actylis’ presence in the VMS and OTC markets
  2. AI in pharma: the trends and future of the tech in the industry AI can enhance the efficiency and cost-effectiveness of a range of processes across the pharmaceutical industry, so S&P Global explores the current scope of the tech and its...
  3. Piramal Pharma debuts its sustainability report for 2023–24 The third annual report is themed around building resilience and revolves around Piramal's four main areas of focus
  4. Xybion launches AI-enabled LIMS technology, LIMS 10.0 The laboratory information management system (LIMS) can improve a lab's functionality and efficiency for users across a vast range of industries
  5. AstraZeneca's asthma-targeting Airsupra meets primary endpoint in Phase III trial The inhaled therapeutic has proven effective in reducing the risk of severe asthma attacks in patients with intermittent or persistent asthma

Upcoming event

ISCC

15-18 October 2024 | Conference | Milan, Italy See all

Related Content

Regulatory

BIA responds to NICE methods and processes review

Going forward, the BIA will continue to work with NICE as it implements these changes to its manual
Finance

UK biotech raises $1.5bn in record quarter

The investment picture has been matched by rising share prices
Research & Development

The power of national collaboration

To expedite the scale-up and production of a COVID-19 vaccine, the UK BioIndustry Association issued a call to arms to its members, reports Steve Bates, CEO
Research & Development

UK Government puts forward revised biopharma R&D tax credit cap

The UK BioIndustry Association has welcomed revised proposals to ensure genuine biotech companies are not penalised by a cap on R&D tax credits
Regulatory

Waiting in the shadow of a no deal Brexit

Pharmaceutical companies still do not know how they will be impacted by Brexit after Prime Minister Theresa May decided to postpone a vote on her deal with the European Union (EU), writes Paul Brooks, Executive Director, RAPS
Regulatory

NHS, Pharma and Biotech industries call on Government to protect patients in future UK-EU relationship

A coalition from the UK’s health sector say Brexit negotiators have a responsibility to protect 500 million patients on both sides of the Channel. The group is calling on both sides to make patients and public health central to the Political Declaration for the future relationship between the UK and the EU
Regulatory

MPs back amendment to keep UK in EU medicines regulatory network

Industry insiders comment on disruptions to the supply of medicines post-Brexit and what the MPs backed amendment means for British patients
Subscribe now